Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
- PMID: 32048130
- PMCID: PMC7090748
- DOI: 10.1007/s12250-020-00204-7
Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Drug combination therapy for emerging viral diseases.Drug Discov Today. 2021 Oct;26(10):2367-2376. doi: 10.1016/j.drudis.2021.05.008. Epub 2021 May 21. Drug Discov Today. 2021. PMID: 34023496 Free PMC article. Review.
-
Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.Trends Microbiol. 2021 Sep;29(9):836-848. doi: 10.1016/j.tim.2021.01.014. Epub 2021 Feb 19. Trends Microbiol. 2021. PMID: 33618979 Review.
-
New pathogenic viruses and novel antiviral drugs.Expert Rev Anti Infect Ther. 2011 Feb;9(2):161-3. doi: 10.1586/eri.10.166. Expert Rev Anti Infect Ther. 2011. PMID: 21342061
-
Intervention strategies for emerging viruses: use of antivirals.Curr Opin Virol. 2013 Apr;3(2):217-24. doi: 10.1016/j.coviro.2013.03.001. Epub 2013 Apr 4. Curr Opin Virol. 2013. PMID: 23562753 Free PMC article. Review.
-
Repositioning of Antibiotics in the Treatment of Viral Infections.Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7. Curr Microbiol. 2024. PMID: 39460768 Free PMC article. Review.
Cited by
-
Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?Nutrients. 2020 Jun 10;12(6):1737. doi: 10.3390/nu12061737. Nutrients. 2020. PMID: 32532069 Free PMC article. Review.
-
In-line treatments and clinical initiatives to fight against COVID-19 outbreak.Respir Med. 2022 Jan;191:106192. doi: 10.1016/j.rmed.2020.106192. Epub 2020 Oct 17. Respir Med. 2022. PMID: 33199136 Free PMC article. Review.
-
The prospects of employing probiotics in combating COVID-19.Tzu Chi Med J. 2021 Oct 5;34(2):148-159. doi: 10.4103/tcmj.tcmj_104_21. eCollection 2022 Apr-Jun. Tzu Chi Med J. 2021. PMID: 35465282 Free PMC article. Review.
-
Polypharmacology guided drug repositioning approach for SARS-CoV2.PLoS One. 2023 Aug 9;18(8):e0289890. doi: 10.1371/journal.pone.0289890. eCollection 2023. PLoS One. 2023. PMID: 37556478 Free PMC article.
-
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020. Front Immunol. 2020. PMID: 32849654 Free PMC article. Review.
References
-
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
-
- Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, Flint M, McMullan LK, Siegel D, Clarke MO, Mackman RL, Hui HC, Perron M, Ray AS, Cihlar T, Nichol ST, Spiropoulou CF. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep. 2017;7:43395. doi: 10.1038/srep43395. - DOI - PMC - PubMed
-
- National Health Commission of the People’s Republic of China (2020) http://www.nhc.gov.cn/xcs/yqfkdt/202001/e71bd2e7a0824ca69f87bbf1bef2a3c9... - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical